Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million on January 18, 2018. As of January 18, 2018, United State Bankruptcy Court, District of Massachusetts, approved the transaction.